Osteonecrosis de los maxilares asociada a medicamentos: Revisión de la literatura y propuesta para la prevención y manejo

Simple item page
dc.coverageDOI: 10.4067/S0034-98872020000700983
dc.creatorFoncea, Camila
dc.creatorvon Bischhoffshausen, Kristine
dc.creatorTeuber, Cristián
dc.creatorRamírez, Hernán
dc.creatorGoñi, Ignacio
dc.creatorSánchez, Cesar
dc.creatorRetamal, Ignacio N.
dc.creatorVargas, Alex
dc.date2020
dc.date.accessioned2025-11-18T19:54:23Z
dc.date.available2025-11-18T19:54:23Z
dc.description<p>Medication-related osteonecrosis of the jaw is a disease where there is necrotic bone exposed or that can be explored by means of a fistula in the maxillofacial region. It has been associated with the use Biphosphonates and denosumab for osteoporosis. Although its etiology is unclear, it may be related to a decrease in bone turnover produced by these drugs, rendering the bone more prone to generate cell necrosis during invasive dental procedures, especially in the posterior region of the jaw. There is no consensus about the prevention and treatment of this condition. The aim of this paper is to present a review of the literature with the main characteristics of osteonecrosis of the jaws associated with drugs, together with a proposal for prevention and treatment for these patients.</p>eng
dc.identifierhttps://investigadores.uandes.cl/en/publications/d23bf9f3-b19f-48c7-9da8-c4601d9df45a
dc.identifier.urihttps://repositorio.uandes.cl/handle/uandes/58730
dc.languagespa
dc.rightsinfo:eu-repo/semantics/openAccess
dc.sourcevol.148 (2020) nr.7 p.983-991
dc.subjectAngiogenesis Inhibitors
dc.subjectBisphosphonate-Associated Osteonecrosis of the Jaw
dc.subjectBone Density Conservation Agents
dc.subjectDiphosphonates
dc.subjectOsteonecrosis
dc.titleOsteonecrosis de los maxilares asociada a medicamentos: Revisión de la literatura y propuesta para la prevención y manejospa
dc.titleOsteonecrosis of the jawseng
dc.typeReview articleeng
dc.typeArtículo de revisiónspa
Files
Collections
PURE